Comparison of Clinical Characteristics of Pneumococcal and non-Pneumococcal Streptococcal Pneumonia

被引:0
|
作者
Jo, Yu Mi [1 ]
Song, Young [1 ]
Choi, Won Suk [1 ]
Heo, Jung Yeon [1 ]
Noh, Ji Youn [1 ]
Kim, Woo Joo [1 ]
Cheong, Hee Jin [1 ]
机构
[1] Korea Univ, Coll Med, Dept Internal Med, Seoul, South Korea
关键词
Community-acquired pneumonia; Pneumococcal pneumonia; Streptococcus;
D O I
10.3947/ic.2010.42.4.223
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Although Pneumococcal (SPN) pneumonia is the most common cause of community-acquired pneumonia, non-pneumococcal streptococcal (NSPN) pneumonia is also frequently reported. However, there are insufficient data on characteristics of NSPN pneumonia which makes it difficult to decide treatment plans or to assess the prognosis. Materials and Methods: Between March 2002 and February 2009, medical records including clinical and epidemiological data on patients aged >= 18 years with community-acquired streptococcal pneumonia were reviewed retrospectively. Clinical characteristics were compared between community-acquired NSPN pneumonia and SPN pneumonia. Results: During the 7 year study periods, 248 patients were hospitalized with community-acquired streptococcal pneumonia and 30 of them had NSPN pneumonia. There were 12 cases of Streptococcus constellatus, 7 cases of S. anginosus, 4 cases of S. mitis, 3 cases of S. pyogenes, 2 cases of S. oralis, 1 case of S. alactolyticus and 1 case of S. agalactiae. There was no difference in percentage of patients with a chronic underlying disease between SPN and NSPN pneumonia groups. The most common was chronic obstructive pulmonary disease (SPN 29.8%, NSPN 16.7%) followed by diabetes mellitus (SPN 22.0%, NSPN 13.3%). Bacteremia (SPN 7.3%, NSPN 20.0%, P=0.04) and empyema (SPN 1.4%, NSPN 53.3%, P<0.001) were more common in NSPN pneumonia. However, there was no significant difference in the CURB-65 pneumonia severity score and 30-day mortality between the two groups. According to multivariate analysis results, the significant risk factor for NSPN pneumonia was the history of frequent alcohol drinking (Adjusted OR 3.81, 95% CI 1.36 to 10.67). Conclusion: Pneumonia caused by NPSN is more commonly accompanied by bacteremia and empyema compared to SPN pneumonia, but there was no difference in the 30-day mortality between the two groups. NSPN pneumonia should be considered if a patient with a history of chronic alcoholism presents with pneumonia and pleural effusion, especially when Gram positive diplococci is seen in the sputum Gram stain.
引用
收藏
页码:223 / 229
页数:7
相关论文
共 50 条
  • [41] Vasculotide reduces pulmonary hyperpermeability in experimental pneumococcal pneumonia
    Gutbier, Birgitt
    Jiang, Xiaohui
    Dietert, Kristina
    Ehrler, Carolin
    Lienau, Jasmin
    Van Slyke, Paul
    Kim, Harold
    Hoang, Van C.
    Maynes, Jason T.
    Dumont, Daniel J.
    Gruber, Achim D.
    Weissmann, Norbert
    Mitchell, Timothy J.
    Suttorp, Norbert
    Witzenrath, Martin
    CRITICAL CARE, 2017, 21
  • [42] Pneumococcal pneumonia: differences according to blood culture results
    Capelastegui, Alberto
    Zalacain, Rafael
    Bilbao, Amaia
    Egurrola, Mikel
    Ruiz Iturriaga, Luis Alberto
    Quintana, Jose M.
    Gomez, Ainhoa
    Esteban, Cristobal
    Espana, Pedro P.
    BMC PULMONARY MEDICINE, 2014, 14
  • [43] Kinase Activity Profiling of Pneumococcal Pneumonia
    Hoogendijk, Arie J.
    Diks, Sander H.
    van der Poll, Tom
    Peppelenbosch, Maikel P.
    Wieland, Catharina W.
    PLOS ONE, 2011, 6 (04):
  • [44] Therapeutic options for pneumococcal pneumonia in Turkey
    Oncu, S
    Erdem, H
    Pahsa, A
    CLINICAL THERAPEUTICS, 2005, 27 (06) : 674 - 683
  • [45] Pathogenesis, treatment, and prevention of pneumococcal pneumonia
    van der Poll, Tom
    Opal, Steven M.
    LANCET, 2009, 374 (9700) : 1543 - 1556
  • [46] Pneumococcal vaccines for prevention of adult pneumonia
    Morimoto, Konosuke
    Masuda, Shingo
    RESPIRATORY INVESTIGATION, 2025, 63 (01) : 96 - 101
  • [47] Drug Treatment of Pneumococcal Pneumonia in the Elderly
    Sridhar Neralla
    Keith C. Meyer
    Drugs & Aging, 2004, 21 : 851 - 864
  • [48] Influenza infection and bacteremic pneumococcal pneumonia
    Blot, M.
    Bruyere, R.
    Chavanet, P.
    Dalle, F.
    Piroth, L.
    Quenot, J. P.
    Charles, P. E.
    MEDECINE ET MALADIES INFECTIEUSES, 2019, 49 (06): : 483 - 484
  • [49] Effect of vaccination on non-integer dynamics of pneumococcal pneumonia infection
    Yasmin, Humaira
    CHAOS SOLITONS & FRACTALS, 2022, 158
  • [50] Drug-resistant pneumococcal pneumonia: clinical relevance and approach to management
    J. D. Fuller
    A. McGeer
    D. E. Low
    European Journal of Clinical Microbiology and Infectious Diseases, 2005, 24 : 780 - 788